GRI Earnings GRI Bio, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.61 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -121.80 | 2026-01-30 | 10-K |
| Q3 2025 | 2025-09-30 | -5.19 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -4.33 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -162.30 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -1545.55 | 2026-01-30 | 10-K |
| Q3 2025 | 2024-09-30 | -77.55 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -150.32 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -101.05 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -5018.09 | 2025-03-14 | 10-K |
| Q3 2024 | 2023-09-30 | -449.34 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -433.14 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -15.04 | 2024-05-10 | 10-Q |
| FY 2023 | 2022-12-31 | -24.95 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.06 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.70 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -11.62 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -1.42 | 2023-02-24 | 10-K |
| Q3 2022 | 2021-09-30 | -0.96 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.79 | 2022-07-28 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.